| Source: |
| Type: |
| Power to enhance an anti cancer effect |
| 5990- | Chit, | Chitosan Nanoparticles for Targeted Cancer Therapy: A Review of Stimuli-Responsive, Passive, and Active Targeting Strategies |
| - | Review, | Var, | NA |
| 4479- | Chit, | Chitosan nanoparticles triggered the induction of ROS-mediated cytoprotective autophagy in cancer cells |
| - | in-vitro, | Cerv, | HeLa | - | in-vitro, | HCC, | SMMC-7721 cell |
| 4490- | Chit, | FA, | Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives |
| - | Review, | Var, | NA |
| 4489- | Chit, | SeNPs, | Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy |
| - | in-vitro, | GBM, | U87MG |
| 4477- | Chit, | Recent Advances in Chitosan and its Derivatives in Cancer Treatment |
| - | Review, | Var, | NA |
| 6078- | CHL, | Update on the bioavailability and chemopreventative mechanisms of dietary chlorophyll derivatives |
| - | Review, | Nor, | NA |
| 6065- | CHL, | Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin |
| - | Review, | HCC, | NA |
| 6077- | CHL, | Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose-dose matrix biomarker and tumor study |
| - | in-vivo, | Var, | NA |
| 6079- | CHL, | Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice |
| - | in-vivo, | Nor, | NA |
| 6069- | CHL, | PDT, | Anti-Cancer Effect of Chlorophyllin-Assisted Photodynamic Therapy to Induce Apoptosis through Oxidative Stress on Human Cervical Cancer |
| - | in-vitro, | Cerv, | HeLa |
| 6076- | CHL, | Effects of chlorophyll and chlorophyllin on low-dose aflatoxin B(1) pharmacokinetics in human volunteers |
| - | Human, | Nor, | NA |
| 6093- | CHOC, | The relevance of theobromine for the beneficial effects of cocoa consumption |
| - | Review, | Nor, | NA | - | NA, | Asthma, | NA |
| 6086- | CHOC, | Cocoa and Chocolate in Human Health and Disease |
| - | Review, | Var, | NA |
| 6088- | CHOC, | Effect of chocolate on older patients with cancer in palliative care: a randomised controlled study |
| - | Trial, | Var, | NA |
| 6107- | Chol, | Choline supplements: An update |
| - | Review, | AD, | NA |
| 6111- | Chol, | The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease |
| - | Human, | AD, | NA |
| 6113- | Chol, | Association between choline supplementation and Alzheimer’s disease risk: a systematic review protocol |
| - | Review, | AD, | NA |
| 6108- | Chol, | Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 6121- | Chol, | Dietary Choline Supplements, but Not Eggs, Raise Fasting TMAO Levels in Participants with Normal Renal Function: A Randomized Clinical Trial |
| - | Human, | AD, | NA |
| 6118- | Chol, | Comparison of the effects of choline alphoscerate and citicoline in patients with dementia disorders: a systematic review and meta-analysis |
| - | Review, | AD, | NA |
| 6103- | Chol, | Dietary Choline Supplementation Attenuates High-Fat-Diet-Induced Hepatocellular Carcinoma in Mice |
| - | in-vivo, | HCC, | NA |
| 6098- | Chol, | Choline |
| - | Review, | Nor, | NA | - | Review, | AD, | NA |
| 3704- | Chol, | Acetylcholine, aging, and Alzheimer's disease |
| - | Review, | AD, | NA |
| 3701- | Chol, | Lifelong choline supplementation ameliorates Alzheimer's disease pathology and associated cognitive deficits by attenuating microglia activation |
| - | in-vivo, | AD, | NA |
| 6133- | CHr, | effect_on_HeLa_cells?">Chrysin in PI3K/AKT and other apoptosis signalling pathways, and its effect on HeLa cells. |
| - | Review, | Var, | NA |
| 6131- | CHr, | Bor, | Z, | Fabrication of phenyl boronic acid modified pH-responsive zinc oxide nanoparticles as targeted delivery of chrysin on human A549 cells |
| - | in-vitro, | Lung, | A549 |
| 6135- | CHr, | Chrysin as a Multifunctional Therapeutic Flavonoid: Emerging Insights in Pathogenesis Management: A Narrative Review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6138- | CHr, | Cisplatin, | Chrysin protects against cisplatin-induced colon. toxicity via amelioration of oxidative stress and apoptosis: Probable role of p38MAPK and p53 |
| - | in-vivo, | Nor, | NA |
| 6124- | CHr, | EGCG, | The anticancer flavonoid chrysin induces the unfolded protein response in hepatoma cells |
| - | in-vitro, | HCC, | HepG2 |
| 6123- | CHr, | Developing nutritional component chrysin as a therapeutic agent: Bioavailability and pharmacokinetics consideration, and ADME mechanisms |
| - | Review, | Nor, | NA |
| 2789- | CHr, | Anticancer Activity of Ether Derivatives of Chrysin |
| - | Review, | Var, | NA |
| 6627- | Cic, | Determination of Cichoric Acid as a Biomarker in Echinacea Purpurea Cultivated in Iran Using High Performance Liquid Chromatography |
| - | Study, | Nor, | NA |
| 6629- | Cic, | Chicoric Acid: Natural Occurrence, Chemical Synthesis, Biosynthesis, and Their Bioactive Effects |
| - | Review, | Nor, | NA |
| 6140- | Cin, | HCAs, | Cinnamaldehyde: Pharmacokinetics, anticancer properties and therapeutic potential (Review) |
| - | Review, | Var, | NA |
| 6147- | Citrate, | The dual role of citrate in cancer |
| - | Review, | Var, | NA |
| 6148- | Citrate, | immuno, | Sodium Citrate Nanoparticles Induce Dual-Path Pyroptosis for Enhanced Antitumor Immunotherapy through Synergistic Ion Overload and Metabolic Disturbance |
| - | in-vitro, | Var, | NA |
| 1592- | Citrate, | Inhibition of Mcl-1 expression by citrate enhances the effect of Bcl-xL inhibitors on human ovarian carcinoma cells |
| - | in-vitro, | Ovarian, | SKOV3 | - | in-vitro, | Ovarian, | IGROV1 |
| 1585- | Citrate, | Sodium citrate targeting Ca2+/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer |
| - | in-vitro, | Ovarian, | SKOV3 | - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Nor, | HEK293 |
| 1584- | Citrate, | Anticancer effects of high-dose extracellular citrate treatment in pancreatic cancer cells under different glucose concentrations |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | PC, | PANC1 |
| 1581- | Citrate, | Hypothesis proved. . .citric acid (citrate) does improve cancer:A case of a patient suffering from medullary thyroid cancer |
| - | Case Report, | Thyroid, | NA |
| 1578- | Citrate, | Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update |
| - | Review, | Var, | NA |
| 1577- | Citrate, | Citric acid promotes SPARC release in pancreatic cancer cells and inhibits the progression of pancreatic tumors in mice on a high-fat diet |
| - | in-vivo, | PC, | NA | - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | PATU-8988 | - | in-vitro, | PC, | MIA PaCa-2 |
| 1576- | Citrate, | Targeting citrate as a novel therapeutic strategy in cancer treatment |
| - | Review, | Var, | NA |
| 2315- | Citrate, | immuno, | Why and how citrate may sensitize malignant tumors to immunotherapy |
| - | Review, | Var, | NA |
| 6155- | CoQ10, | BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference |
| - | Review, | Var, | NA |
| - | vitro+vivo, | GBM, | U251 |
| 6152- | CoQ10, | doxoR, | Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q10 on Doxorubicin Pharmacokinetics during Breast Cancer Treatment |
| - | Trial, | BC, | NA |
| 4767- | CoQ10, | Efficacy of Coenzyme Q10 for Improved Tolerability of Cancer Treatments: A Systematic Review |
| - | Review, | Var, | NA |
| 4772- | CoQ10, | The anti-tumor activities of coenzyme Q0 through ROS-mediated autophagic cell death in human triple-negative breast cells |
| - | in-vitro, | BC, | MDA-MB-468 | - | in-vitro, | BC, | MDA-MB-231 |
| 4776- | CoQ10, | Antitumor properties of Coenzyme Q0 against human ovarian carcinoma cells via induction of ROS-mediated apoptosis and cytoprotective autophagy |
| - | vitro+vivo, | Ovarian, | SKOV3 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:961 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid